Skip to main content
Top
Published in: Sports Medicine 11/2003

01-09-2003 | Review Article

Exercise-Induced Changes in Coagulation and Fibrinolysis in Healthy Populations and Patients with Cardiovascular Disease

Authors: Dr Christopher J. Womack, Paul R. Nagelkirk, Adam M. Coughlin

Published in: Sports Medicine | Issue 11/2003

Login to get access

Abstract

This review highlights the clinical significance of coagulation and fibrinolytic responses, and adaptations in healthy individuals and patients with cardiovascular disease (CVD). Much of the review focuses on indicators of the potential for coagulation and fibrinolysis. The terms ‘coagulation potential’ and ‘fibrinolytic potential’ are used frequently, as much of the literature in the area of exercise haemostasis evaluates factors that reflect an increased potential for coagulation, while coagulation per se, may or may not be occurring. Similarly, fibrinolysis is definitively the lysis of inappropriate or excessive blood clot, which may or may not be occurring when the enzymes that stimulate fibrinolysis are activated. Nevertheless, markers of coagulation and fibrinolytic potential are associated with CVD, ischaemic events, and cardiovascular mortality. Additionally, fibrinolytic potential is associated with other established CVD risk factors. Ischaemic events triggered by physical exertion are more likely to occur due to an occlusive thrombus, suggesting the exercise-induced responses related to haemostasis are of clinical significance.
The magnitude of increase in coagulation potential, platelet aggregation and fibrinolysis appears to be primarily determined by exercise intensity. Patients with CVD may also have a larger increase in coagulation potential during acute exercise than healthy individuals. Additionally, the magnitude of the fibrinolytic response is largely related to the resting fibrinolytic profile of the individual. In particular, high resting plasminogen activator inhibitor-1 may diminish the magnitude of tissue plasminogen activator response during acute exercise. Therefore, acute responses to exercise may increase the risk of ischaemic event. However, chronic aerobic exercise training may decrease coagulation potential and increase fibrinolytic potential in both healthy individuals and CVD patients. Due to the aforementioned importance of resting fibrinolysis on the fibrinolytic response to exercise, chronic aerobic exercise training may cause favourable adaptations that could contribute to decreased risk for ischaemic event, both at rest and during physical exertion.
Literature
1.
go back to reference Davies MJ, Bland JM, Hangartner JRW, et al. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J 1989; 10: 203–8PubMed Davies MJ, Bland JM, Hangartner JRW, et al. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J 1989; 10: 203–8PubMed
2.
go back to reference Muller JE, Kaufmann PG, Luepker RV, et al. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. Circulation 1997; 96: 3233–9PubMedCrossRef Muller JE, Kaufmann PG, Luepker RV, et al. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. Circulation 1997; 96: 3233–9PubMedCrossRef
4.
go back to reference Folsom AR, Wu KK, Shahar E., et al. Association of hemostatic variables with prevalent cardiovascular-disease and asymptomatic carotid-artery atherosclerosis. Arterioscler Thromb 1993; 13: 1829–36PubMedCrossRef Folsom AR, Wu KK, Shahar E., et al. Association of hemostatic variables with prevalent cardiovascular-disease and asymptomatic carotid-artery atherosclerosis. Arterioscler Thromb 1993; 13: 1829–36PubMedCrossRef
5.
go back to reference Pan WH, Bai CH, Chen JR, et al. Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension. Stroke 1997; 28: 88–94PubMedCrossRef Pan WH, Bai CH, Chen JR, et al. Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension. Stroke 1997; 28: 88–94PubMedCrossRef
6.
go back to reference Woodward M, Lowe GDO, Rumley A, et al. Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women: the Scottish Heart Health Study. Br J Haematol 1997; 97: 785–97PubMedCrossRef Woodward M, Lowe GDO, Rumley A, et al. Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women: the Scottish Heart Health Study. Br J Haematol 1997; 97: 785–97PubMedCrossRef
7.
go back to reference Giannitssis E, Siemens HJ, Mitusch R, et al. Prothrombin framents F1 + 2, thrombin-antithrombin complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis. Int J Cardiol 1999; 68: 269–74CrossRef Giannitssis E, Siemens HJ, Mitusch R, et al. Prothrombin framents F1 + 2, thrombin-antithrombin complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis. Int J Cardiol 1999; 68: 269–74CrossRef
8.
go back to reference Cavusoglu Y, Gorenek B, Alpsoy S, et al. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease. Isr Med Assoc J 2001; 3: 13–6PubMed Cavusoglu Y, Gorenek B, Alpsoy S, et al. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease. Isr Med Assoc J 2001; 3: 13–6PubMed
9.
go back to reference deMaat MPM, Pietersma A, Kofflard M, et al. Association of plasma fibrinogen levels with coronary artery disease, smoking, and inflammatory markers. Atherosclerosis 1996; 121: 185–91CrossRef deMaat MPM, Pietersma A, Kofflard M, et al. Association of plasma fibrinogen levels with coronary artery disease, smoking, and inflammatory markers. Atherosclerosis 1996; 121: 185–91CrossRef
10.
go back to reference Meade TW, Ruddock V, Stirling Y, et al. Fibrinolytic activity, clotting factors, and long-term incidence of ischemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076–9PubMedCrossRef Meade TW, Ruddock V, Stirling Y, et al. Fibrinolytic activity, clotting factors, and long-term incidence of ischemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076–9PubMedCrossRef
11.
go back to reference Saito I, Folsom AR, Brancati FL, et al. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (AR-IC) Study. Ann Intern Med 2000; 133: 81–91PubMed Saito I, Folsom AR, Brancati FL, et al. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (AR-IC) Study. Ann Intern Med 2000; 133: 81–91PubMed
12.
go back to reference Thompson SG, Kienast J, Pyke SDM, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635–41PubMedCrossRef Thompson SG, Kienast J, Pyke SDM, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635–41PubMedCrossRef
13.
go back to reference Tribouilloy C, Peltier M, Colas L, et al. Fibrinogen is an independent marker for thoracic aortic atherosclerosis. Am J Cardiol 1998; 81: 321–6PubMedCrossRef Tribouilloy C, Peltier M, Colas L, et al. Fibrinogen is an independent marker for thoracic aortic atherosclerosis. Am J Cardiol 1998; 81: 321–6PubMedCrossRef
14.
go back to reference Tracy RP, Arnold AM, Ettinger W, et al. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 1776–83PubMedCrossRef Tracy RP, Arnold AM, Ettinger W, et al. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 1776–83PubMedCrossRef
15.
go back to reference Acevedo M, Foody JM, Pearce GL, et al. Fibrinogen: associations with cardiovascular events in an outpatient clinic. Am Heart J 2002; 143: 277–82PubMedCrossRef Acevedo M, Foody JM, Pearce GL, et al. Fibrinogen: associations with cardiovascular events in an outpatient clinic. Am Heart J 2002; 143: 277–82PubMedCrossRef
16.
go back to reference Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemie stroke. Circulation 1999; 100: 736–42PubMedCrossRef Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemie stroke. Circulation 1999; 100: 736–42PubMedCrossRef
17.
go back to reference Wilhelmsen L, Svardsudd K, Korsanbengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501–5PubMedCrossRef Wilhelmsen L, Svardsudd K, Korsanbengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501–5PubMedCrossRef
18.
go back to reference Mustonen P, Lepantalo M, Lassila R. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis. Arterioscler Thromb Vasc Biol 1998; 18: 244–9PubMedCrossRef Mustonen P, Lepantalo M, Lassila R. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis. Arterioscler Thromb Vasc Biol 1998; 18: 244–9PubMedCrossRef
19.
go back to reference Tracy RP, Bovill EG, Yanez D, et al. Fibrinogen and Factor-VIII, but not Factor VII, are associated with measures of subclinical cardiovascular-disease in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 1995; 15: 1269–79PubMedCrossRef Tracy RP, Bovill EG, Yanez D, et al. Fibrinogen and Factor-VIII, but not Factor VII, are associated with measures of subclinical cardiovascular-disease in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 1995; 15: 1269–79PubMedCrossRef
20.
go back to reference Rice GI, Grant PJ. FVIII coagulant activity and antigen in subjects with ischaemic heart disease. Thromb Haemost 1998; 80: 757–62PubMed Rice GI, Grant PJ. FVIII coagulant activity and antigen in subjects with ischaemic heart disease. Thromb Haemost 1998; 80: 757–62PubMed
21.
go back to reference Yamauchi K, Suzuki T, Furumichi T, et al. Plasma tPA/PAI-1 complex and blood coagulability in patients with coronary-artery disease. Jpn Heart J 1992; 33: 351–8PubMedCrossRef Yamauchi K, Suzuki T, Furumichi T, et al. Plasma tPA/PAI-1 complex and blood coagulability in patients with coronary-artery disease. Jpn Heart J 1992; 33: 351–8PubMedCrossRef
22.
go back to reference Jansson J-H, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Eur Heart J 1991; 66: 351–5CrossRef Jansson J-H, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Eur Heart J 1991; 66: 351–5CrossRef
23.
go back to reference Catto AJ, Carter AM, Barrett JH, et al. von Willebrand factor and factor VIII: c in acute cerebrovascular disease: relationship to stroke subtype and mortality. Thromb Haemost 1997; 77: 1104–8PubMed Catto AJ, Carter AM, Barrett JH, et al. von Willebrand factor and factor VIII: c in acute cerebrovascular disease: relationship to stroke subtype and mortality. Thromb Haemost 1997; 77: 1104–8PubMed
24.
go back to reference Ray SA, Rowley MR, Loh A, et al. Hypercoagulable states in patients with leg ischemia. Br J Surg 1994; 81: 811–4PubMedCrossRef Ray SA, Rowley MR, Loh A, et al. Hypercoagulable states in patients with leg ischemia. Br J Surg 1994; 81: 811–4PubMedCrossRef
25.
go back to reference Dawson S, Henney A. The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review. Atherosclerosis 1992; 95: 105–17PubMedCrossRef Dawson S, Henney A. The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review. Atherosclerosis 1992; 95: 105–17PubMedCrossRef
26.
go back to reference Killewich LA, Gardner AW, Macko RF, et al. Progressive intermittent claudication is associated with impaired fibrinolysis. J Vasc Surg 1998; 27: 645–50PubMedCrossRef Killewich LA, Gardner AW, Macko RF, et al. Progressive intermittent claudication is associated with impaired fibrinolysis. J Vasc Surg 1998; 27: 645–50PubMedCrossRef
27.
go back to reference Salomaa V, Stinson V, Kark JD, et al. Association of fibrinolytic parameters with early atherosclerosis. Circulation 1995; 91: 284–90PubMedCrossRef Salomaa V, Stinson V, Kark JD, et al. Association of fibrinolytic parameters with early atherosclerosis. Circulation 1995; 91: 284–90PubMedCrossRef
28.
go back to reference Smith FB, Lee AJ, Rumley A, et al. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Atherosclerosis 1995; 115: 35–43PubMedCrossRef Smith FB, Lee AJ, Rumley A, et al. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Atherosclerosis 1995; 115: 35–43PubMedCrossRef
29.
go back to reference van der Bom JG, Bots ML, Haverkate F, et al. Fibrinolytic activity in peripheral atherosclerosis in the elderly. Thromb Haemost 1999; 81: 275–80PubMed van der Bom JG, Bots ML, Haverkate F, et al. Fibrinolytic activity in peripheral atherosclerosis in the elderly. Thromb Haemost 1999; 81: 275–80PubMed
30.
go back to reference Paramo JA, Olavide I, Barba J, et al. Long-term cardiac rehabilitation program favorably influences fibrinolysis and lipid concentrations in acute myocardial infarction. Haematologica 1998; 83: 519–24PubMed Paramo JA, Olavide I, Barba J, et al. Long-term cardiac rehabilitation program favorably influences fibrinolysis and lipid concentrations in acute myocardial infarction. Haematologica 1998; 83: 519–24PubMed
31.
go back to reference Sakata K, Kurata C, Taguchi T, et al. Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemia. Am Heart J 1990; 120: 831–8PubMedCrossRef Sakata K, Kurata C, Taguchi T, et al. Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemia. Am Heart J 1990; 120: 831–8PubMedCrossRef
32.
go back to reference Cortellaro M, Cofrancesco E, Boschetti C, et al. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. Arterioscler Thromb 1993; 13: 1412–7PubMedCrossRef Cortellaro M, Cofrancesco E, Boschetti C, et al. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. Arterioscler Thromb 1993; 13: 1412–7PubMedCrossRef
33.
go back to reference Cushman M, Lemaitre RN, Kuller LH, et al. Fibrinolytic activation markers predict myocardial infarction in the elderly: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 493–8PubMedCrossRef Cushman M, Lemaitre RN, Kuller LH, et al. Fibrinolytic activation markers predict myocardial infarction in the elderly: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 493–8PubMedCrossRef
34.
go back to reference Grzywacz A, Elikowski W, Psuja P, et al. Impairment of plasma fibrinolysis in young survivors of myocardial infarction with silent ischaemia. Blood Coagul Fibrinolysis 1998; 9: 245–9PubMedCrossRef Grzywacz A, Elikowski W, Psuja P, et al. Impairment of plasma fibrinolysis in young survivors of myocardial infarction with silent ischaemia. Blood Coagul Fibrinolysis 1998; 9: 245–9PubMedCrossRef
35.
go back to reference Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; II: 3–9CrossRef Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; II: 3–9CrossRef
36.
go back to reference Johansson L, Jansson JH, Boman K, et al. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke 2000; 31: 26–32PubMedCrossRef Johansson L, Jansson JH, Boman K, et al. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke 2000; 31: 26–32PubMedCrossRef
37.
go back to reference Lindgren A, Lindoff C, Norrving B, et al. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 1996; 27: 1066–71PubMedCrossRef Lindgren A, Lindoff C, Norrving B, et al. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 1996; 27: 1066–71PubMedCrossRef
38.
go back to reference Jansson J-H, Olofsson B-O, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. Circulation 1993; 88: 2030–4PubMedCrossRef Jansson J-H, Olofsson B-O, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. Circulation 1993; 88: 2030–4PubMedCrossRef
39.
go back to reference Fendri S, Roussel B, Lormeau B, et al. Insulin sensitivity, insulin action, and fibrinolysis activity in nondiabetic and diabetic obese subjects. Metabolism 1998; 47: 1372–5PubMedCrossRef Fendri S, Roussel B, Lormeau B, et al. Insulin sensitivity, insulin action, and fibrinolysis activity in nondiabetic and diabetic obese subjects. Metabolism 1998; 47: 1372–5PubMedCrossRef
40.
go back to reference Keber I, Keber D. Increased plasminogen activator inhibitor activity in survivors of myocardial infarction is associated with metabolic risk factors of atherosclerosis. Haemostasis 1992; 22: 187–94PubMed Keber I, Keber D. Increased plasminogen activator inhibitor activity in survivors of myocardial infarction is associated with metabolic risk factors of atherosclerosis. Haemostasis 1992; 22: 187–94PubMed
41.
go back to reference Sundell IB, Nilsson TK, Ranby M, et al. Fibrinoloytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjo, Sweden. J Clin Epidemiol 1989; 42: 719–23PubMedCrossRef Sundell IB, Nilsson TK, Ranby M, et al. Fibrinoloytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjo, Sweden. J Clin Epidemiol 1989; 42: 719–23PubMedCrossRef
42.
go back to reference Asplund-Carlson A, Hamsten A, Wiman B, et al. Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertrig-lyceridaemic men. Diabetologia 1993; 36: 817–25PubMedCrossRef Asplund-Carlson A, Hamsten A, Wiman B, et al. Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertrig-lyceridaemic men. Diabetologia 1993; 36: 817–25PubMedCrossRef
43.
go back to reference Jansson JH, Johansson B, Bowman K, et al. Hypo-fibrinolysis in patients with hypertension and elevated cholesterol. J Intern Med 1991; 229(4): 309–16PubMedCrossRef Jansson JH, Johansson B, Bowman K, et al. Hypo-fibrinolysis in patients with hypertension and elevated cholesterol. J Intern Med 1991; 229(4): 309–16PubMedCrossRef
44.
go back to reference Mehta J, Mehta P, Lawson D, et al. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 1987; 9: 263–8PubMedCrossRef Mehta J, Mehta P, Lawson D, et al. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 1987; 9: 263–8PubMedCrossRef
45.
go back to reference Ragosta M, Crabtree J, Sturner WQ, et al. Death during recreational exercise in the state of Rhode Island. Med Sci Sports Exerc 1984; 16: 339–42PubMed Ragosta M, Crabtree J, Sturner WQ, et al. Death during recreational exercise in the state of Rhode Island. Med Sci Sports Exerc 1984; 16: 339–42PubMed
46.
go back to reference Toiler GH, Stone PH, Maclure M, et al. Analysis of possible triggers of acute myocardial infarction. Am J Cardiol 1990; 66: 22–7CrossRef Toiler GH, Stone PH, Maclure M, et al. Analysis of possible triggers of acute myocardial infarction. Am J Cardiol 1990; 66: 22–7CrossRef
47.
go back to reference Giri S, Thompson PD, Kiernan FJ, et al. Clinical and angiographie characteristics of exertion-related acute myocardial infarction. JAMA 1999; 282: 1731–6PubMedCrossRef Giri S, Thompson PD, Kiernan FJ, et al. Clinical and angiographie characteristics of exertion-related acute myocardial infarction. JAMA 1999; 282: 1731–6PubMedCrossRef
48.
go back to reference Bartsch P., Welsch B, Albert M, et al. Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc 1995; 27: 1465–70PubMed Bartsch P., Welsch B, Albert M, et al. Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc 1995; 27: 1465–70PubMed
49.
go back to reference Hilberg T, Nowacki PE, Muller-Berghaus G, et al. Changes in blood coagulation and fibrinolysis associated with maximal exercise and physical conditioning in women taking low dose oral contraceptives. J Sci Med Sport 2000; 3: 383–90PubMedCrossRef Hilberg T, Nowacki PE, Muller-Berghaus G, et al. Changes in blood coagulation and fibrinolysis associated with maximal exercise and physical conditioning in women taking low dose oral contraceptives. J Sci Med Sport 2000; 3: 383–90PubMedCrossRef
50.
go back to reference Rocker L, Gunay S, Gunga HC, et al. Activation of blood platelets in response to maximal isometric exercise of the dominant arm. Int J Sports Med 2000; 21: 191–4PubMedCrossRef Rocker L, Gunay S, Gunga HC, et al. Activation of blood platelets in response to maximal isometric exercise of the dominant arm. Int J Sports Med 2000; 21: 191–4PubMedCrossRef
51.
go back to reference van den Burg PJM, Hospers JEH, van Vliet M, et al. Changes in haemostatic factors and activation products after exercise in healthy subjects with different ages. Thromb Haemost 1995; 74: 1457–64PubMed van den Burg PJM, Hospers JEH, van Vliet M, et al. Changes in haemostatic factors and activation products after exercise in healthy subjects with different ages. Thromb Haemost 1995; 74: 1457–64PubMed
52.
go back to reference Ferguson EW, Bernier LL, Banta GR, et al. Effects of exercise and conditioning on clotting and fibrinolytic activity in men. J Appl Physiol 1987; 62: 1416–21PubMedCrossRef Ferguson EW, Bernier LL, Banta GR, et al. Effects of exercise and conditioning on clotting and fibrinolytic activity in men. J Appl Physiol 1987; 62: 1416–21PubMedCrossRef
53.
go back to reference Molz AB, Heyduck B, Lill H, et al. The effect of different exercise intensities on the fibrinolytic system. Eur J Appl Physiol Occup Physiol 1993; 67(4): 298–304PubMedCrossRef Molz AB, Heyduck B, Lill H, et al. The effect of different exercise intensities on the fibrinolytic system. Eur J Appl Physiol Occup Physiol 1993; 67(4): 298–304PubMedCrossRef
54.
go back to reference Weiss C, Bierhaus A, Kinscherf R, et al. Tissue factor-dependent pathway is not involved in exercise-induced formation of thrombin and fibrin. J Appl Physiol 2002; 92: 211–8PubMed Weiss C, Bierhaus A, Kinscherf R, et al. Tissue factor-dependent pathway is not involved in exercise-induced formation of thrombin and fibrin. J Appl Physiol 2002; 92: 211–8PubMed
55.
go back to reference Mockel M, Ulrich NV, Heller Jr G, et al. Platelet activation through triathlon competition in ultra-endurance trained athletes: impact of thrombin and plasmin generation and catecholamine release. Int J Sports Med 2001; 22: 337–43PubMedCrossRef Mockel M, Ulrich NV, Heller Jr G, et al. Platelet activation through triathlon competition in ultra-endurance trained athletes: impact of thrombin and plasmin generation and catecholamine release. Int J Sports Med 2001; 22: 337–43PubMedCrossRef
56.
go back to reference Prisco D, Paniccia R, Bandinelli B, et al. Evaluation of clotting and fibrinolytic activation after protracted physical exercise. Thromb Res 1998; 89: 73–8PubMedCrossRef Prisco D, Paniccia R, Bandinelli B, et al. Evaluation of clotting and fibrinolytic activation after protracted physical exercise. Thromb Res 1998; 89: 73–8PubMedCrossRef
57.
go back to reference Weiss C, Welsch B, Albert M, et al. Coagulation and thrombomodulin in response to exercise of different type and duration. Med Sci Sports Exerc 1998; 30: 1205–10PubMedCrossRef Weiss C, Welsch B, Albert M, et al. Coagulation and thrombomodulin in response to exercise of different type and duration. Med Sci Sports Exerc 1998; 30: 1205–10PubMedCrossRef
58.
go back to reference Wallen NH, Goodall AH, Li N, et al. Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation. Clin Sci (Lond) 1999; 97: 27–35CrossRef Wallen NH, Goodall AH, Li N, et al. Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation. Clin Sci (Lond) 1999; 97: 27–35CrossRef
59.
go back to reference Arai M, Yorifuji H, Ikematsu S, et al. Influences of strenuous exercise (triathlon) on blood coagulation and fibrinolytic system. Thromb Res 1990; 57: 465–71PubMedCrossRef Arai M, Yorifuji H, Ikematsu S, et al. Influences of strenuous exercise (triathlon) on blood coagulation and fibrinolytic system. Thromb Res 1990; 57: 465–71PubMedCrossRef
60.
go back to reference Hegde SS, Goldfarb AH, Hegde S. Clotting and fibrinolytic activity change during the 1h after a submaximal run. Med Sci Sports Exerc 2001; 33: 887–92PubMedCrossRef Hegde SS, Goldfarb AH, Hegde S. Clotting and fibrinolytic activity change during the 1h after a submaximal run. Med Sci Sports Exerc 2001; 33: 887–92PubMedCrossRef
61.
go back to reference Lin X, El-Sayed S, Waterhouse J, et al. Activation and disturbance of blood haemostasis following strenuous physical exercise. Int J Sports Med 1999; 20: 149–53PubMed Lin X, El-Sayed S, Waterhouse J, et al. Activation and disturbance of blood haemostasis following strenuous physical exercise. Int J Sports Med 1999; 20: 149–53PubMed
62.
go back to reference van den Burg PJM, Hospers JEH, van Vliet M, et al. Effect of endurance training and seasonal fluctuation on coagulation and fibrinolysis in young sedentary men. J Appl Physiol 1997; 82: 613–20PubMed van den Burg PJM, Hospers JEH, van Vliet M, et al. Effect of endurance training and seasonal fluctuation on coagulation and fibrinolysis in young sedentary men. J Appl Physiol 1997; 82: 613–20PubMed
63.
go back to reference Andrew M, Carter C, O’Brodovich H, et al. Increases in factor VIII complex and fibrinolytic activity are dependent on exercise intensity. J Appl Physiol 1986; 60: 1917–22PubMed Andrew M, Carter C, O’Brodovich H, et al. Increases in factor VIII complex and fibrinolytic activity are dependent on exercise intensity. J Appl Physiol 1986; 60: 1917–22PubMed
64.
go back to reference Womack CJ, Rasmussen JM, Vickers DG, et al. Fibrinolytic response to high and low-intensity exercise. Med Sci Sports Exerc 2001; 33 Suppl.: S303 Womack CJ, Rasmussen JM, Vickers DG, et al. Fibrinolytic response to high and low-intensity exercise. Med Sci Sports Exerc 2001; 33 Suppl.: S303
65.
go back to reference Weiss C, Seitel G, Bartsch P. Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 1998; 30: 246–51PubMed Weiss C, Seitel G, Bartsch P. Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 1998; 30: 246–51PubMed
66.
go back to reference Cohen RJ, Epstein SE, Cohen LS, et al. Alterations in blood fibrinolysis, and blood coagulation induced by exercise and the role of beta-adrenergic receptor stimulation. Lancet 1968; II: 1264–6CrossRef Cohen RJ, Epstein SE, Cohen LS, et al. Alterations in blood fibrinolysis, and blood coagulation induced by exercise and the role of beta-adrenergic receptor stimulation. Lancet 1968; II: 1264–6CrossRef
67.
go back to reference Jilma B, Dirnberger E, Eichler HG, et al. Partial blockade of nitric oxide synthase blunts the exercise-induced increase of von Willebrand factor antigen and of factor VIII in man. Thromb Haemost 1997; 78: 1268–71PubMed Jilma B, Dirnberger E, Eichler HG, et al. Partial blockade of nitric oxide synthase blunts the exercise-induced increase of von Willebrand factor antigen and of factor VIII in man. Thromb Haemost 1997; 78: 1268–71PubMed
68.
go back to reference Hjemdahl P, Larsson PT, Wallen NH. Effects of stress and beta-blockade on platelet function. Circulation 1991; 84 (6 Suppl.): VI44–61PubMed Hjemdahl P, Larsson PT, Wallen NH. Effects of stress and beta-blockade on platelet function. Circulation 1991; 84 (6 Suppl.): VI44–61PubMed
69.
go back to reference Larsson PT, Wallen NH, Egberg N, et al. Alpha-adrenoceptor blockade by phentolamine inhibits adrenaline-induced platelet activation in vivo without affecting resting measurements. Clin Sci (Lond) 1992; 82: 369–76 Larsson PT, Wallen NH, Egberg N, et al. Alpha-adrenoceptor blockade by phentolamine inhibits adrenaline-induced platelet activation in vivo without affecting resting measurements. Clin Sci (Lond) 1992; 82: 369–76
70.
go back to reference Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994; 89: 1951–7PubMedCrossRef Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994; 89: 1951–7PubMedCrossRef
71.
go back to reference Kawano TA, Aoki N, Homori M, et al. Mental stress and physical exercise increase platelet-dependent thrombin generation. Heart Vessels 2000; 15: 280–8PubMedCrossRef Kawano TA, Aoki N, Homori M, et al. Mental stress and physical exercise increase platelet-dependent thrombin generation. Heart Vessels 2000; 15: 280–8PubMedCrossRef
72.
go back to reference Elhadj S, Mousa SA, Forsten-Williams K. Chronic pulsatile shear stress impacts synthesis of proteoglycans by endothelial cells: effect on platelet aggregation and coagulation. J Cell Biochem 2002; 86: 239–50PubMedCrossRef Elhadj S, Mousa SA, Forsten-Williams K. Chronic pulsatile shear stress impacts synthesis of proteoglycans by endothelial cells: effect on platelet aggregation and coagulation. J Cell Biochem 2002; 86: 239–50PubMedCrossRef
73.
go back to reference Moritz MW, Reimers RC, Baker RK, et al. Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress. J Lab Clin Med 1983; 101: 537–44PubMed Moritz MW, Reimers RC, Baker RK, et al. Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress. J Lab Clin Med 1983; 101: 537–44PubMed
75.
go back to reference De Buyzere M, Philippe J, Duprez D, et al. Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease. Am J Hematol 1993; 43: 91–4PubMedCrossRef De Buyzere M, Philippe J, Duprez D, et al. Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease. Am J Hematol 1993; 43: 91–4PubMedCrossRef
76.
go back to reference Suzuki T, Yamauchi K, Yamada Y, et al. Blood coagulability and fibrinolytic activity before and after physical training during the recovery phase of acute myocardial infarction. Clin Cardiol 1992; 15: 358–64PubMedCrossRef Suzuki T, Yamauchi K, Yamada Y, et al. Blood coagulability and fibrinolytic activity before and after physical training during the recovery phase of acute myocardial infarction. Clin Cardiol 1992; 15: 358–64PubMedCrossRef
77.
go back to reference Bartsch P, Haeberli A, Straub PW. Blood coagulation after long distance running: antithrombin III prevents fibrin formation. Thromb Hemost 1990; 63: 430–4 Bartsch P, Haeberli A, Straub PW. Blood coagulation after long distance running: antithrombin III prevents fibrin formation. Thromb Hemost 1990; 63: 430–4
78.
go back to reference Herren T, Bartsch S, Haeberli A, et al. Increased thrombin-antithrombin III complexes after 1h of physical exercise. J Appl Physiol 1992; 73: 499–504 Herren T, Bartsch S, Haeberli A, et al. Increased thrombin-antithrombin III complexes after 1h of physical exercise. J Appl Physiol 1992; 73: 499–504
79.
go back to reference Rankinen T, Vaisanen S, Penttila I, et al. Acute dynamic exercise increases fibrinolytic activity. Thromb Haemost 1995; 73: 281–6PubMed Rankinen T, Vaisanen S, Penttila I, et al. Acute dynamic exercise increases fibrinolytic activity. Thromb Haemost 1995; 73: 281–6PubMed
80.
go back to reference Watts EJ. Hemostatic changes in long-distance runners and their relevance to the prevention of ischemic heart disease. Blood Coagul Fibrinolysis 1991; 2: 221–5PubMedCrossRef Watts EJ. Hemostatic changes in long-distance runners and their relevance to the prevention of ischemic heart disease. Blood Coagul Fibrinolysis 1991; 2: 221–5PubMedCrossRef
81.
go back to reference Brull DJ, Dhamrait S, Moulding R, et al. The effect of fibrinogen genotype on fibrinogen levels after strenuous physical exercise. Thromb Haemost 2002; 87: 37–41PubMed Brull DJ, Dhamrait S, Moulding R, et al. The effect of fibrinogen genotype on fibrinogen levels after strenuous physical exercise. Thromb Haemost 2002; 87: 37–41PubMed
82.
go back to reference Montgomery HE, Clarkson P, Nwose OM, et al. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene. Arterioscler Thromb Vasc Biol 1996; 16: 386–91PubMedCrossRef Montgomery HE, Clarkson P, Nwose OM, et al. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene. Arterioscler Thromb Vasc Biol 1996; 16: 386–91PubMedCrossRef
83.
go back to reference Wannamethee SG, Lowe GD, Whincup PH, et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002; 105: 1785–90PubMedCrossRef Wannamethee SG, Lowe GD, Whincup PH, et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002; 105: 1785–90PubMedCrossRef
84.
go back to reference Geffken D, Cushman M, Burke G, et al. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001; 153: 242–50PubMedCrossRef Geffken D, Cushman M, Burke G, et al. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001; 153: 242–50PubMedCrossRef
85.
go back to reference van den Burg PJ, Hospers JE, Mosterd WL, et al. Aging, physical conditioning, and exercise-induced changes in hemostatic factors and reaction products. J Appl Physiol 2000; 88: 1558–64PubMed van den Burg PJ, Hospers JE, Mosterd WL, et al. Aging, physical conditioning, and exercise-induced changes in hemostatic factors and reaction products. J Appl Physiol 2000; 88: 1558–64PubMed
86.
go back to reference Gris JC, Schved JF, Feugeas O, et al. Impact of smoking, physical training and weight reduction on FVII, PAI-1 and hemostatic markers in sedentary men. Thromb Haemost 1990; 64: 516–20PubMed Gris JC, Schved JF, Feugeas O, et al. Impact of smoking, physical training and weight reduction on FVII, PAI-1 and hemostatic markers in sedentary men. Thromb Haemost 1990; 64: 516–20PubMed
87.
go back to reference Folsom AR, Arnett DK, Hutchinson RG, et al. Physical activity and incidence of coronary heart disease (CHD) in middle aged women and men. Med Sci Sports Exerc 1997; 29: 901–9PubMedCrossRef Folsom AR, Arnett DK, Hutchinson RG, et al. Physical activity and incidence of coronary heart disease (CHD) in middle aged women and men. Med Sci Sports Exerc 1997; 29: 901–9PubMedCrossRef
88.
go back to reference Connelly JB, Cooper JA, Meade TW. Strenuous exercise, plasma fibrinogen, and factor VII activity. Br Heart J 1992; 67: 351–4PubMedCrossRef Connelly JB, Cooper JA, Meade TW. Strenuous exercise, plasma fibrinogen, and factor VII activity. Br Heart J 1992; 67: 351–4PubMedCrossRef
89.
go back to reference Abramson JL, Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002; 162: 1286–92PubMedCrossRef Abramson JL, Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002; 162: 1286–92PubMedCrossRef
90.
go back to reference Lakka TA, Salonen JT. Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men. J Clin Epidemiol 1993; 46: 1119–27PubMedCrossRef Lakka TA, Salonen JT. Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men. J Clin Epidemiol 1993; 46: 1119–27PubMedCrossRef
91.
go back to reference Wosornu D, Allardyce W, Ballantyne D, et al. Influence of power and aerobic exercise training on hemostatic factors after coronary artery surgery. Br Heart J 1992; 68: 181–6PubMedCrossRef Wosornu D, Allardyce W, Ballantyne D, et al. Influence of power and aerobic exercise training on hemostatic factors after coronary artery surgery. Br Heart J 1992; 68: 181–6PubMedCrossRef
92.
go back to reference Ernst E, Schmid M. Regular aerobic exercise lowers fibrinogen levels: results of a pilot study. Phys Med Rehab 1993; 3: 196–8 Ernst E, Schmid M. Regular aerobic exercise lowers fibrinogen levels: results of a pilot study. Phys Med Rehab 1993; 3: 196–8
93.
go back to reference Schuit AJ, Schouten EG, Kluft C, et al. Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderly men and women. Thromb Haemost 1997; 78: 845–51PubMed Schuit AJ, Schouten EG, Kluft C, et al. Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderly men and women. Thromb Haemost 1997; 78: 845–51PubMed
94.
go back to reference Rankinen T, Rauramaa R, Väisänen S, et al. Blood coagulation and fibrinolytic factors are unchanged by aerobic exercise of fat modified diet: randomized clinical trial in middle-aged men. Fibrinolysis 1994; 8: 1–6 Rankinen T, Rauramaa R, Väisänen S, et al. Blood coagulation and fibrinolytic factors are unchanged by aerobic exercise of fat modified diet: randomized clinical trial in middle-aged men. Fibrinolysis 1994; 8: 1–6
95.
go back to reference Rauramaa R, Väisänen SB, Kuhanen R, et al. The Rsal polymorphism in the alpha-fibrinogen gene and response of plasma fibrinogen to physical training: a controlled randomised clinical trial in men. Thromb Haemost 2000; 83: 803–6PubMed Rauramaa R, Väisänen SB, Kuhanen R, et al. The Rsal polymorphism in the alpha-fibrinogen gene and response of plasma fibrinogen to physical training: a controlled randomised clinical trial in men. Thromb Haemost 2000; 83: 803–6PubMed
96.
go back to reference Svendsen OL, Hassager C, Christiansen C, et al. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: effect of dieting with or without exercise in overweight postmenopausal women. Arterioscler Thromb Vasc Biol 1996; 16: 381–5PubMedCrossRef Svendsen OL, Hassager C, Christiansen C, et al. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: effect of dieting with or without exercise in overweight postmenopausal women. Arterioscler Thromb Vasc Biol 1996; 16: 381–5PubMedCrossRef
97.
go back to reference Tisi PV, Hulse M, Chulakadabba A, et al. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 1997; 14: 344–50PubMedCrossRef Tisi PV, Hulse M, Chulakadabba A, et al. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 1997; 14: 344–50PubMedCrossRef
98.
go back to reference Rauramaa R, Väisänen SB. Dose-response and coagulation and hemostatic factors. Med Sci Sports Exerc 2001; 33: S516–20PubMedCrossRef Rauramaa R, Väisänen SB. Dose-response and coagulation and hemostatic factors. Med Sci Sports Exerc 2001; 33: S516–20PubMedCrossRef
99.
go back to reference Davis RB, Boyd DG, McKinney ME, et al. Effects of exercise and exercise conditioning on blood platelet function. Med Sci Sports Exerc 1990; 22: 49–53PubMed Davis RB, Boyd DG, McKinney ME, et al. Effects of exercise and exercise conditioning on blood platelet function. Med Sci Sports Exerc 1990; 22: 49–53PubMed
100.
go back to reference Rauramaa R, Salonen JT, Seppanen K, et al. Inhibition of platelet aggregability by moderate-intensity physical exercise: a randomized clinical trial in overweight men. Circulation 1986 Nov; 74: 939–44PubMedCrossRef Rauramaa R, Salonen JT, Seppanen K, et al. Inhibition of platelet aggregability by moderate-intensity physical exercise: a randomized clinical trial in overweight men. Circulation 1986 Nov; 74: 939–44PubMedCrossRef
101.
go back to reference Wang JS, Jen CJ, Chen HI. Effects of exercise training and deconditioning on platelet function in men. Arterioscler Thromb Vasc Biol 1995; 15: 1668–74PubMedCrossRef Wang JS, Jen CJ, Chen HI. Effects of exercise training and deconditioning on platelet function in men. Arterioscler Thromb Vasc Biol 1995; 15: 1668–74PubMedCrossRef
102.
go back to reference Wang JS, Jen CJ, Chen HI. Effects of chronic exercise and deconditioning on platelet function in women. J Appl Physiol 1997; 83: 2080–5PubMed Wang JS, Jen CJ, Chen HI. Effects of chronic exercise and deconditioning on platelet function in women. J Appl Physiol 1997; 83: 2080–5PubMed
103.
go back to reference Prowse CV, Cash JD. Physiologic and pharmacologic enhancement of fibrinolysis. Semin Thromb Hemost 1984; 10: 51–60PubMedCrossRef Prowse CV, Cash JD. Physiologic and pharmacologic enhancement of fibrinolysis. Semin Thromb Hemost 1984; 10: 51–60PubMedCrossRef
104.
go back to reference Streiff M, Bell WR. Exercise and hemostasis in humans. Semin Hematol 1996; 31: 155–65 Streiff M, Bell WR. Exercise and hemostasis in humans. Semin Hematol 1996; 31: 155–65
105.
go back to reference Davis GL, Abildgaard CF, Bernauer EM, et al. Fibrinolytic and hemostatic changes during and after maximal exercise in males. J Appl Physiol 1976; 40: 287–92PubMed Davis GL, Abildgaard CF, Bernauer EM, et al. Fibrinolytic and hemostatic changes during and after maximal exercise in males. J Appl Physiol 1976; 40: 287–92PubMed
106.
go back to reference Mazzeo RS, Marshall P. Influence of plasma catecholamines on the lactate threshold during graded exercise. J Appl Physiol 1989; 67: 1319–22PubMed Mazzeo RS, Marshall P. Influence of plasma catecholamines on the lactate threshold during graded exercise. J Appl Physiol 1989; 67: 1319–22PubMed
107.
go back to reference Kooistra T, Schrauwen Y, Arts J, et al. Regulation of endothelial cell t-PA synthesis and release. Int J Hematol 1994; 59: 233–55PubMed Kooistra T, Schrauwen Y, Arts J, et al. Regulation of endothelial cell t-PA synthesis and release. Int J Hematol 1994; 59: 233–55PubMed
108.
go back to reference Jern C, Ladenvall P, Wall U, et al. Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA. Arterioscler Thromb Vasc Biol 1999; 19: 454–9PubMedCrossRef Jern C, Ladenvall P, Wall U, et al. Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA. Arterioscler Thromb Vasc Biol 1999; 19: 454–9PubMedCrossRef
109.
go back to reference DeSouza CA, Jones PP, Seals DR. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors. Arterioscler Thomb Vasc Biol 1998; 18: 362–8CrossRef DeSouza CA, Jones PP, Seals DR. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors. Arterioscler Thomb Vasc Biol 1998; 18: 362–8CrossRef
110.
go back to reference Speiser W, Langer W, Pschaick A, et al. Increased blood fibrinolytic activity after physical exercise: comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program. Thromb Res 1988; 51(5): 543–55PubMedCrossRef Speiser W, Langer W, Pschaick A, et al. Increased blood fibrinolytic activity after physical exercise: comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program. Thromb Res 1988; 51(5): 543–55PubMedCrossRef
111.
go back to reference Kvernmo HD, Osterud B. The effect of physical conditioning suggests adaptation in procoagulant and fibrinolytic potential. Thromb Res 1997; 87(6): 559–69PubMedCrossRef Kvernmo HD, Osterud B. The effect of physical conditioning suggests adaptation in procoagulant and fibrinolytic potential. Thromb Res 1997; 87(6): 559–69PubMedCrossRef
112.
go back to reference De Paz JA, Lasierra J, Villa JG, et al. Changes in the fibrinolytic system associated with physical conditioning. Eur J Appl Physiol 1992; 65: 388–93CrossRef De Paz JA, Lasierra J, Villa JG, et al. Changes in the fibrinolytic system associated with physical conditioning. Eur J Appl Physiol 1992; 65: 388–93CrossRef
113.
go back to reference Yarnell JWG, Sweetnam PM, Rumley A, et al. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler Thromb Vase Biol 2000; 20: 271–9CrossRef Yarnell JWG, Sweetnam PM, Rumley A, et al. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler Thromb Vase Biol 2000; 20: 271–9CrossRef
114.
go back to reference El-Sayed MS. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med 1996; 22: 282–98PubMedCrossRef El-Sayed MS. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med 1996; 22: 282–98PubMedCrossRef
115.
go back to reference Stratton JR, Chandler WL, Schwartz RS, et al. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 1991; 83: 1692–7PubMedCrossRef Stratton JR, Chandler WL, Schwartz RS, et al. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 1991; 83: 1692–7PubMedCrossRef
116.
go back to reference Szymanski LM, Pate RR. Effects of exercise intensity, duration, and time of day on fibrinolytic activity in physically active men. Med Sci Sports Exerc 1994; 26: 1102–8PubMed Szymanski LM, Pate RR. Effects of exercise intensity, duration, and time of day on fibrinolytic activity in physically active men. Med Sci Sports Exerc 1994; 26: 1102–8PubMed
117.
go back to reference Weiss C, Velich T, Niebauer J, et al. Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease. Am J Cardiol 1998; 81: 672–7PubMedCrossRef Weiss C, Velich T, Niebauer J, et al. Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease. Am J Cardiol 1998; 81: 672–7PubMedCrossRef
118.
go back to reference Estelles A, Torino G, Aznar J, et al. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise. Thromb Res 1985; 40: 373–83PubMedCrossRef Estelles A, Torino G, Aznar J, et al. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise. Thromb Res 1985; 40: 373–83PubMedCrossRef
119.
go back to reference Rydzewski A, Sakata K, Kobayashi A, et al. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease. Haemostasis 1990; 20: 305–12PubMed Rydzewski A, Sakata K, Kobayashi A, et al. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease. Haemostasis 1990; 20: 305–12PubMed
120.
go back to reference Fernhall B, Szymanski LM, Gorman PA, et al. Fibrinolytic activity is similar in physically active men with and without a history of myocardial infarction. Arterioscler Thromb Vasc Biol 1997; 17: 1106–13PubMedCrossRef Fernhall B, Szymanski LM, Gorman PA, et al. Fibrinolytic activity is similar in physically active men with and without a history of myocardial infarction. Arterioscler Thromb Vasc Biol 1997; 17: 1106–13PubMedCrossRef
121.
go back to reference Dart AM, Cooper B, Kay SB, et al. Relationships between protein C, protein S, von Willebrand factor and euglobulin lysis time and cardiovascular risk factors in subjects with and without coronary heart disease. Atherosclerosis 1998; 140: 55–64PubMedCrossRef Dart AM, Cooper B, Kay SB, et al. Relationships between protein C, protein S, von Willebrand factor and euglobulin lysis time and cardiovascular risk factors in subjects with and without coronary heart disease. Atherosclerosis 1998; 140: 55–64PubMedCrossRef
122.
go back to reference Womack CJ, Ivey FM, Gardner AW, et al. Fibrinolytic response to acute exercise in patients with peripheral arterial occlusive disease. Med Sci Sports Exerc 2001; 33(2): 214–9PubMed Womack CJ, Ivey FM, Gardner AW, et al. Fibrinolytic response to acute exercise in patients with peripheral arterial occlusive disease. Med Sci Sports Exerc 2001; 33(2): 214–9PubMed
123.
go back to reference Zanettini R, Bettega D, Agostoni O, et al. Exercise training in mild hypertension: effects on blood pressure, left ventricular mass and coagulation factor VII and fibrinogen. Cardiology 1997; 88: 468–73PubMedCrossRef Zanettini R, Bettega D, Agostoni O, et al. Exercise training in mild hypertension: effects on blood pressure, left ventricular mass and coagulation factor VII and fibrinogen. Cardiology 1997; 88: 468–73PubMedCrossRef
124.
go back to reference Dunstan DW, Mori TA, Puddey IB, et al. A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics. Thromb Haemost 1999; 81: 367–72PubMed Dunstan DW, Mori TA, Puddey IB, et al. A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics. Thromb Haemost 1999; 81: 367–72PubMed
125.
go back to reference Lindahl B, Nilsson TK, Jansson J-H, et al. Improved fibrinolysis by intense lifestyle intervention: a randomized trial in subjects with impaired glucose tolerance. J Intern Med 1999; 246: 105–12PubMedCrossRef Lindahl B, Nilsson TK, Jansson J-H, et al. Improved fibrinolysis by intense lifestyle intervention: a randomized trial in subjects with impaired glucose tolerance. J Intern Med 1999; 246: 105–12PubMedCrossRef
126.
go back to reference Lindahl B, Nilsson TK, Asplund K, et al. Intense nonpharmaco-logical intervention in subjects with multiple cardiovascular risk factors: decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity. Metabolism 1998; 47: 384–90PubMedCrossRef Lindahl B, Nilsson TK, Asplund K, et al. Intense nonpharmaco-logical intervention in subjects with multiple cardiovascular risk factors: decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity. Metabolism 1998; 47: 384–90PubMedCrossRef
127.
go back to reference Estelles A, Aznar J, Tormo G, et al. Influence of a rehabilitation sports programme on the fibrinolytic activity of patients after myocardial infarction. Thromb Res 1989; 55: 203–12PubMedCrossRef Estelles A, Aznar J, Tormo G, et al. Influence of a rehabilitation sports programme on the fibrinolytic activity of patients after myocardial infarction. Thromb Res 1989; 55: 203–12PubMedCrossRef
Metadata
Title
Exercise-Induced Changes in Coagulation and Fibrinolysis in Healthy Populations and Patients with Cardiovascular Disease
Authors
Dr Christopher J. Womack
Paul R. Nagelkirk
Adam M. Coughlin
Publication date
01-09-2003
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 11/2003
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.2165/00007256-200333110-00002

Other articles of this Issue 11/2003

Sports Medicine 11/2003 Go to the issue